쓰리빌리언

394800KOSDAQ자연과학 및 공학 연구개발업

51.0 / 100

Reference Date: 2026-07-24

Financial Score14.0 / 40

News Sentiment20.0 / 25

Momentum7.0 / 20

Disclosure10.0 / 15

AI Analysis: PBR raises overvaluation concerns, ROE is below the industry average. Declined 8.6% over the past month, and news sentiment is positive.

Company InformationBased on 2025 Annual Report

Business Overview

3billion is a company leading the diagnosis and development of treatments for rare diseases using AI-based genome interpretation technology, offering genetic testing services such as whole genome and whole exome sequencing. As of 2025, it generates revenue in 75 countries, with 67.4% of sales coming from overseas, and has launched its own genetic variant interpretation software 'GEBRA' as a SaaS product.

Number of Employees

196people

Average Salary

67.2M KRW

Score Calculation Basis

Detailed Financial Score

PER

—Industry Average 43.644.0Point

PBR

7.88Industry Average 2.520.0Point

3.1x industry avg (risky)

ROE

-20.87Industry Average -32.093.5Point

Below industry avg

Debt Ratio

11.50Industry Average 7.310.5Point

1.6x industry avg (risky)

Trend 2024~20256.0 / 10 points

Revenue Growth Rate

3.0 / 3

Avg ▲102.8% (1-year basis)

Operating Profit Growth Rate

3.0 / 3

Avg ▲20.6% (1-year basis)

ROE Trend

0.0 / 4

Avg ROE -26.8% (improving, 2yr)

Detailed News Sentiment

9 totalPositive 8Neutral 1Negative 0Average Sentiment Score 80

Positive
쓰리빌리언, 병무청장과 전문연구요원 소통 간담회 진행
쓰리빌리언이 병무청장과의 간담회를 통해 전문연구요원 지원 정책에 대한 협력 강화를 논의하며 긍정적인 시장 반응을 이끌어냈다.
Positive
금창원 쓰리빌리언 대표 "AI 우수인재 확보 지속"
쓰리빌리언의 AI 전문 인력 확보 계획 발표로 인해 긍정적인 시장 반응 예상.
Neutral
"사회문제 풀수록 더 큰 수익…임팩트 투자의 본질은 '+α'"
기사는 임팩트 투자의 본질을 설명하지만, 특정 종목인 쓰리빌리언의 직접적인 영향은 언급되지 않음.

Detailed Momentum

52-week position1.0Point

Near 52w low (3%, downtrend)

Current 5,840Won52-week high 18,80052-week low 5,350

1-month return1.0Point

1m -8.61% (falling)

Volume trend5.0Point

Volume flat

Detailed Disclosure

0 totalPositive 0Neutral 0Negative 0